Cargando…
IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi
INTRODUCTION: An estimated 1.5 million cases were reported in Pakistan until 23 March, 2022. However, SARS-CoV-2 PCR testing capacity has been limited and the incidence of COVID-19 infections is unknown. Volunteer healthy blood donors can be a control population for assessment of SARS-CoV-2 exposure...
Autores principales: | Hasan, Muhammad, Moiz, Bushra, Qaiser, Shama, Masood, Kiran Iqbal, Ghous, Zara, Hussain, Areeba, Ali, Natasha, Simas, J. Pedro, Veldhoen, Marc, Alves, Paula, Abidi, Syed Hani, Ghias, Kulsoom, Khan, Erum, Hasan, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401161/ https://www.ncbi.nlm.nih.gov/pubmed/36001587 http://dx.doi.org/10.1371/journal.pone.0271259 |
Ejemplares similares
-
A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum
por: Abidi, Syed Hani, et al.
Publicado: (2021) -
Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study
por: Hasan, Zahra, et al.
Publicado: (2023) -
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan
por: Masood, Kiran Iqbal, et al.
Publicado: (2023) -
Students’ perception of educational environment at Aga Khan University Medical College, Karachi, Pakistan
por: Rehman, Rehana, et al.
Publicado: (2016) -
Screening for arboviruses in healthy blood donors: Experience from Karachi, Pakistan
por: Khan, Moiz Ahmed, et al.
Publicado: (2022)